Animal anatomy

Vyome Therapeutics Completes Enrollment of Phase 2 Clinical Trial with VB-1953 in Moderate to Severe Inflammatory Acne

Retrieved on: 
Tuesday, November 5, 2019
RTT, Anti-acne preparations, Medicine, Acne, Puberty, Clinical medicine, Animal anatomy, AOBiome, Clascoterone

We are pleased to have completed enrollment in our Phase 2 dose ranging clinical trial of our promising topical therapeutic candidate for the treatment of moderate to severe inflammatory acne said Venkat Nelabhotla, president & chief executive officer of Vyome Therapeutics.

Key Points: 
  • We are pleased to have completed enrollment in our Phase 2 dose ranging clinical trial of our promising topical therapeutic candidate for the treatment of moderate to severe inflammatory acne said Venkat Nelabhotla, president & chief executive officer of Vyome Therapeutics.
  • VB-1953 is currently being studied in a Phase 2 dose ranging clinical trial in the United States.
  • Vyome Therapeutics is a clinical stage specialty pharmaceutical company based in Princeton, New Jersey, developing a deep pipeline of drugs for the treatment of drug-resistant skin pathogens & inflammatory conditions, including for inflammatory acne.
  • Vyome advanced its lead clinical candidate, VB-1953, into a Phase 2 clinical trial for the treatment of moderate to severe inflammatory acne.

WindMIL Therapeutics to Present Data Demonstrating Marrow-Infiltrating Lymphocytes’ (MILs™) Superior Functionality Compared to Peripheral Blood Counterparts at 34th Annual Meeting of the Society for Immunotherapy of Cancer

Retrieved on: 
Tuesday, November 5, 2019
Medical specialties, Animal anatomy, Lymphatic system, Stem cells, Bone marrow, Hematopoiesis, Skeletal system, Cancer immunotherapy, Lymphocyte, Immunotherapy, Immunology

Based on these data and the inherent antitumor properties of MILs, we believe CAR-MILs could be more potent and effective than currently approved CAR-T products derived from peripheral blood lymphocytes, said Eric Lutz, Ph.D., director of research at WindMIL Therapeutics.

Key Points: 
  • Based on these data and the inherent antitumor properties of MILs, we believe CAR-MILs could be more potent and effective than currently approved CAR-T products derived from peripheral blood lymphocytes, said Eric Lutz, Ph.D., director of research at WindMIL Therapeutics.
  • WindMIL is developing both unmodified and gene-modified forms of MILs.
  • Details of the poster presentation are as follows:
    WindMIL Therapeutics is a clinical-stage company developing a novel class of autologous cell therapies based on marrow infiltrating lymphocytes (MILs) for cancer immunotherapy.
  • As the leader in cellular therapeutics emanating from bone marrow, WindMIL translates novel insights in bone marrow immunology into life-saving cancer immunotherapeutics for patients.

November International Hyperhidrosis Awareness Month: No Sweat, No Stress With the miraDry Treatment

Retrieved on: 
Thursday, October 31, 2019
Organ systems, Branches of biology, Hyperhidrosis, Thoracic surgery, Animal anatomy, Focal hyperhidrosis, Body fluids, Excretion, Reflexes, Perspiration, Stress

It manifests as extreme, uncontrollable sweating beyond what's considered "normal" or necessary as a reaction to heat, exercise or stress.

Key Points: 
  • It manifests as extreme, uncontrollable sweating beyond what's considered "normal" or necessary as a reaction to heat, exercise or stress.
  • The miraDry system is intended for use by health care professionals for treatment of primary axillary hyperhidrosis in adults.
  • miraDry and No Sweat No Stress is a trademark of miraDry, Inc. 2019 miraDry, Inc. All rights reserved.
  • Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device.Dermatol Surg.

NanoScan Imaging LLC ("NanoScan") announced the sale of its inventory of N1177 iodinated nanoparticulate and potential impact in oncology diagnostics

Retrieved on: 
Tuesday, October 29, 2019
Medical specialties, Medicine, Animal anatomy, Oncology, Immune system, Lymph node, Metástasis, Lymph, Sentinel lymph node

NORRISTOWN, Pa., Oct. 29, 2019 /PRNewswire-PRWeb/ --Following on the October 25, 2019 announcement that it would be offering for sale its inventory of the breakthrough N1177 nanoparticulate contrast agent, NanoScan Imaging LLC ("NanoScan") released additional details about the compound and its potential in oncology diagnostics.

Key Points: 
  • NORRISTOWN, Pa., Oct. 29, 2019 /PRNewswire-PRWeb/ --Following on the October 25, 2019 announcement that it would be offering for sale its inventory of the breakthrough N1177 nanoparticulate contrast agent, NanoScan Imaging LLC ("NanoScan") released additional details about the compound and its potential in oncology diagnostics.
  • Subcutaneous Injectable N1177, an injectable emulsion made of iodinated nanoparticles, accumulates in macrophages associated with non-cancerous lymph node tissue but not cancerous tissue.
  • N1177, when used in this manner as a CT imaging agent, differentiates cancerous nodes from healthy nodes regardless of node size.
  • Lymph node imaging plays a critical role in staging patients with various metastatic cancers.

Sebacia Announces Oral Presentations Reporting 24-Month EU Real-World Data and 3-Month U.S. Real-World Data of Sebacia Microparticles at ASDS Annual Meeting 2019

Retrieved on: 
Thursday, October 24, 2019
RTT, Acneiform eruptions, Acne, Puberty, Medicine, Animal anatomy, Anti-acne preparations, Anatomy

The study was designed to evaluate acne outcomes in patients that received treatment with common first-line topical acne pharmaceuticals prior to the Sebacia treatment.

Key Points: 
  • The study was designed to evaluate acne outcomes in patients that received treatment with common first-line topical acne pharmaceuticals prior to the Sebacia treatment.
  • The study was designed to largely mirror the European study presented by Dr. Waibel and will continue to gather long-term follow-up data in these patients.
  • Cory Anderson, VP, Clinical Marketing and Business Development, said, "This is a pivotal time for Sebacia as we initiate our targeted launch of Sebacia Microparticles in the U.S.
  • Sebacia Microparticles is cleared for use in the U.S. and in the EU, the two largest dermatology markets in the world.

Perricone MD Launches New Acne Relief Prebiotic Acne Therapy 90-Day Regimen

Retrieved on: 
Wednesday, October 16, 2019
Acneiform eruptions, Acne, Puberty, RTT, Anti-acne preparations, Medicine, Animal anatomy, Anatomy

Acne Relief Prebiotic Acne Therapy is an easy and comprehensive regimen that works with the skin's natural microbiome to safely, gently and effectively treat and prevent the most troublesome acne, while restoring and maintaining a healthy skin balance.

Key Points: 
  • Acne Relief Prebiotic Acne Therapy is an easy and comprehensive regimen that works with the skin's natural microbiome to safely, gently and effectively treat and prevent the most troublesome acne, while restoring and maintaining a healthy skin balance.
  • For added targeted treatment of blemishes, Perricone MD has also launched Acne Relief Maximum Strength Spot Gel.
  • Acne Relief Prebiotic Acne Therapy is clinically proven to be non-irritating and will not strip or over-dry skin.
  • *
    Acne Relief Prebiotic Acne Therapy 90-Day Regimen retails for $89 and is now available on PerriconeMD.com .

Atlantic Urology Brings New Procedure to New Hanover Regional Medical Center

Retrieved on: 
Monday, October 14, 2019
RTT, Anatomy, Men's Health, Organ systems, Animal anatomy, Histopathology, Prostate cancer, Benign prostatic hyperplasia, Prostate

WILMINGTON, N.C., Oct. 14, 2019 /PRNewswire-PRWeb/ -- Dr. Hugh Mallory Reeves treats first patients at New Hanover Regional Medical Center with the UroLift System for Enlarged Prostate.

Key Points: 
  • WILMINGTON, N.C., Oct. 14, 2019 /PRNewswire-PRWeb/ -- Dr. Hugh Mallory Reeves treats first patients at New Hanover Regional Medical Center with the UroLift System for Enlarged Prostate.
  • Atlantic Urology brings UroLift Center of Excellence provider to area.
  • This includes the first patients ever to be treated at New Hanover Regional Medical Center with this revolutionary treatment option for a symptomatic enlarged prostate.
  • He has been designated a UroLift Center of Excellence provider, attesting to his dedication since 2015 in perfecting this procedure for his patients.

Medical Fish Skin Company Kerecis Presents New Research at the Symposium on Advanced Wound Care

Retrieved on: 
Friday, October 11, 2019
Nursing, Biotechnology, Diabetes, Health, Research, Surgery, Hospitals, Science, Medicine, Branches of biology, Medical specialties, Injuries, Animal anatomy, Organs, Skin, Soft tissue, Graft, Wound

Kerecis Omega3 Wound is intact fish skin that, when grafted onto damaged human tissue, recruits the bodys own cells and ultimately is converted into living tissue.

Key Points: 
  • Kerecis Omega3 Wound is intact fish skin that, when grafted onto damaged human tissue, recruits the bodys own cells and ultimately is converted into living tissue.
  • Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal skin substitute.
  • Fish skin is becoming a mainstream therapy for treating severe wounds, including diabetic or burn wounds, said G. Fertram Sigurjonsson, founder and CEO of Kerecis.
  • Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market.

Acne Product Cleans Up the Competition with Top 5-Star Rating from TopConsumerReviews.com

Retrieved on: 
Wednesday, October 2, 2019
Acneiform eruptions, RTT, Cutaneous conditions, Acne, Puberty, Medicine, Clinical medicine, Animal anatomy, Anti-acne preparations

It seems that no one can completely avoid acne: from teenage boys, to women in their 40's, and just about everyone else, acne can affect anyone.

Key Points: 
  • It seems that no one can completely avoid acne: from teenage boys, to women in their 40's, and just about everyone else, acne can affect anyone.
  • For these reasons it's no wonder that an increasing number of people rely on over-the-counter acne products.
  • To find out more about Zenmed and other Acne Products, including reviews and comparison rankings, please visit the Acne Products category of TopConsumerReviews.com at https://www.topconsumerreviews.com/acne/ .
  • From Acne to Eczema and Stress Relief, TopConsumerReviews.com delivers in-depth product evaluations in order to make purchasing decisions.

The Bone Marrow & Cancer Foundation Launches New Patient Program 'Carelines'

Retrieved on: 
Tuesday, October 1, 2019
Medical specialties, Branches of biology, Animal anatomy, Stem cells, Bone marrow, Endocrine system, Hematopoiesis, Skeletal system, Cancer, Gift of Life Marrow Registry

NEW YORK, Oct. 1, 2019 /PRNewswire/ --Today, the Bone Marrow & Cancer Foundation (BMCF) launched their newest patient program, Carelines, to respond to the evolving needs of patients and families undergoing cancer treatment.

Key Points: 
  • NEW YORK, Oct. 1, 2019 /PRNewswire/ --Today, the Bone Marrow & Cancer Foundation (BMCF) launched their newest patient program, Carelines, to respond to the evolving needs of patients and families undergoing cancer treatment.
  • The BMCF works closely with each participating patient to set up a profile, and to promote it through social media and/or more traditional means.
  • It takes a village to get through a diagnosis and having support from their loved ones and community makes all the difference in the world," said Bone Marrow & Cancer Foundation founder and CEO Christina Merrill.
  • About the Bone Marrow & Cancer Foundation:
    The Bone Marrow & Cancer Foundation, founded in 1992, is dedicated to improving the quality of life for cancer and transplant patients and their families by providing vital financial assistance, comprehensive resources, educational information, physician referrals, and emotional support programs.